.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Medtronic
Harvard Business School
QuintilesIMS
Julphar
Healthtrust
Cantor Fitzgerald
Dow
UBS
Teva

Generated: July 24, 2017

DrugPatentWatch Database Preview

Cephradine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cephradine and what is the scope of cephradine patent protection?

Cephradine
is the generic ingredient in six branded drugs marketed by Vitarine, Bristol Myers Squibb, Ersana, Barr, Glaxosmithkline, Ivax Sub Teva Pharms, Apothecon, and Teva, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for cephradine.

Summary for Generic Name: cephradine

Tradenames:6
Patents:1
Applicants:8
NDAs:15
Drug Master File Entries: see list10
Bulk Api Vendors: see list34
Patent Applications: see list4,996
Therapeutic Class:Antibacterials
Drug Prices:see low prices
DailyMed Link:cephradine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
VELOSEF
cephradine
INJECTABLE;INJECTION061976-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ersana
VELOSEF '250'
cephradine
CAPSULE;ORAL050548-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
ANSPOR
cephradine
CAPSULE;ORAL061859-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
CEPHRADINE
cephradine
CAPSULE;ORAL062850-001Apr 22, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
VELOSEF
cephradine
INJECTABLE;INJECTION061976-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Fuji
Dow
Cantor Fitzgerald
Daiichi Sankyo
US Army
Argus Health
Queensland Health
UBS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot